Method for measuring resistance or sensitivity to docetaxel

Details for Australian Patent Application No. 2005314335 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors August, Paul; Grueneberg, Dorre; Natesan, Sridaran; Huang, Xi

Agent Watermark

Pub. Number AU-B-2005314335

PCT Pub. Number WO2006/062811

Priority 60/634,298 08.12.04 US

Filing date 1 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 2 February 2012

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/062811 Priority application(s): WO2006/062811

2 February 2012 Application Accepted

  Published as AU-B-2005314335

26 April 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 10 Apr 2012. Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

16 August 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 10 Apr 2012

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005314346-Punchout contactless transaction card

2005314329-Apparatus for priming microfluidics devices with feedback control